ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,828Medicare Part D Prescriptions Filled, Including Refills

Rank: 252 out of 2170

$813K Total Retail Price of All Prescriptions

Rank: 143 out of 2170

847 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 847 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 847 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 7,789 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 367 245 1 2
FUROSEMIDE 350 224 2 6
AMLODIPINE BESYLATE 349 285 3 4
LISINOPRIL 293 213 4 3
LEVOTHYROXINE SODIUM 259 211 5 5
SIMVASTATIN 256 176 6 1
METOPROLOL TARTRATE 247 182 7 10
PRAVASTATIN SODIUM 225 166 8 11
METFORMIN HCL 216 140 9 8
SERTRALINE HCL 210 183 10 25
METOPROLOL SUCCINATE 193 137 11 13
GABAPENTIN 182 56 12 14
CRESTOR 172 87 13 24
WARFARIN SODIUM 165 125 14 15
ATORVASTATIN CALCIUM 159 126 15 12
POTASSIUM CHLORIDE 154 81 16 16
CLONIDINE HCL 139 43 17 54
NAMENDA 138 138 18 48
CLOPIDOGREL 126 90 19 37
DONEPEZIL HCL 119 110 20 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 118 81 21 20
ZOLPIDEM TARTRATE 112 70 22 17
DIOVAN HCT 112 80 22 76
METFORMIN HCL ER 107 50 24 35
ALLOPURINOL 107 89 24 29
NEXIUM 95 28 26 22
TAMSULOSIN HCL 93 67 27 33
AMLODIPINE BESYLATE-BENAZEPRIL 92 37 28 67
MELOXICAM 92 77 28 28
HYDROCHLOROTHIAZIDE 91 64 30 9
HYDROCODONE-ACETAMINOPHEN 90 65 S3 31 7
MIRTAZAPINE 90 75 31 46
DIOVAN 87 42 33 53
CARVEDILOL 82 54 34 26
PANTOPRAZOLE SODIUM 82 63 34 39
PLAVIX 80 68 36 58
LOSARTAN-HYDROCHLOROTHIAZIDE 77 56 37 42
VENTOLIN HFA 74 40 38 102
LANTUS SOLOSTAR 73 36 39 79
ALENDRONATE SODIUM 70 70 40 36
BENAZEPRIL HCL 70 51 40 55
LANTUS 70 34 40 51
GLIMEPIRIDE 69 37 43 31
FLUOXETINE HCL 67 40 44 59
ISOSORBIDE MONONITRATE ER 66 55 45 50
LOSARTAN POTASSIUM 65 56 46 21
PEN NEEDLE 64 22 47 141
LYRICA 64 30 47 90
TRAMADOL HCL 63 39 49 18
QUETIAPINE FUMARATE 57 46 50 88
DIGOXIN 56 56 51 72
LOVASTATIN 54 45 52 34
PROAIR HFA 54 27 52 43
CYMBALTA 53 26 54 44
BENAZEPRIL-HYDROCHLOROTHIAZIDE 51 28 55 161
AMITRIPTYLINE HCL 51 25 R 55 61
FLUTICASONE PROPIONATE 50 18 57 30
SPIRIVA 50 35 57 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.